Generation Bio Co. logo

Generation Bio Co.

NASDAQ:GBIO

Overview | Financials
Company Name Generation Bio Co.
Symbol GBIO
Currency USD
Price 2.16
Market Cap 144,160,992
Dividend Yield 0%
52-week-range 1.02 - 4.65
Industry Biotechnology
Sector Healthcare
CEO Dr. Cameron Geoffrey McDonough M.D.
Website https://generationbio.com

An error occurred while fetching data.

About Generation Bio Co.

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology.

Related Stocks

Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc.

MCRB

0.807 USD

Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc.

XERS

3.22 USD

SOPHiA GENETICS SA logo

SOPHiA GENETICS SA

SOPH

3.75 USD

Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc.

PHAT

18.94 USD

Zynex, Inc. logo

Zynex, Inc.

ZYXI

8 USD

LianBio logo

LianBio

LIAN

0.319 USD

Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc.

EWTX

34.48 USD

Financials

Numbers are in millions USD

Numbers are in millions USD